Karki S - Search Results

1

Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.

Meruva S, Thool P, Gong Y, Karki S, Bowen W, Kumar S. Meruva S, et al. Among authors: karki s. Int J Pharm. 2020 Mar 15;577:119026. doi: 10.1016/j.ijpharm.2020.119026. Epub 2020 Jan 12. Int J Pharm. 2020. PMID: 31940456

2

Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.

Meruva S, Thool P, Shah S, Karki S, Bowen W, Ghosh I, Kumar S. Meruva S, et al. Among authors: karki s. Int J Pharm. 2019 Sep 10;568:118189. doi: 10.1016/j.ijpharm.2019.03.007. Epub 2019 Mar 6. Int J Pharm. 2019. PMID: 30851385 Free article.

3

Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development - Part II.

Meruva S, Thool P, Karki S, Bowen W, Ghosh I, Kumar S. Meruva S, et al. Among authors: karki s. Int J Pharm. 2019 Sep 10;568:118509. doi: 10.1016/j.ijpharm.2019.118509. Epub 2019 Jul 10. Int J Pharm. 2019. PMID: 31301463

4

Decoding the small size challenges of mini-tablets for enhanced dose flexibility and micro-dosing.

Mitra B, Thool P, Meruva S, Aycinena JA, Li J, Patel J, Patel K, Agarwal A, Karki S, Bowen W. Mitra B, et al. Among authors: karki s. Int J Pharm. 2020 Jan 25;574:118905. doi: 10.1016/j.ijpharm.2019.118905. Epub 2019 Dec 3. Int J Pharm. 2020. PMID: 31809860

5

Development of low dose micro-tablets by high shear wet granulation process.

Gupta S, Thool P, Meruva S, Li J, Patel J, Agrawal A, Karki S, Bowen W, Mitra B. Gupta S, et al. Among authors: karki s. Int J Pharm. 2020 Sep 25;587:119571. doi: 10.1016/j.ijpharm.2020.119571. Epub 2020 Jul 9. Int J Pharm. 2020. PMID: 32652180

6

3D printed bilayer tablet with dual controlled drug release for tuberculosis treatment.

Ghanizadeh Tabriz A, Nandi U, Hurt AP, Hui HW, Karki S, Gong Y, Kumar S, Douroumis D. Ghanizadeh Tabriz A, et al. Among authors: karki s. Int J Pharm. 2021 Jan 25;593:120147. doi: 10.1016/j.ijpharm.2020.120147. Epub 2020 Dec 3. Int J Pharm. 2021. PMID: 33278493

7

A Novel Use of Nanocrystalline Suspensions to Develop Sub-Microgram Dose Micro-Tablets.

Meruva S, Thool P, Gong Y, Agrawal A, Karki S, Bowen W, Mitra B, Kumar S. Meruva S, et al. Among authors: karki s. J Pharm Sci. 2021 Sep;110(9):3276-3288. doi: 10.1016/j.xphs.2021.05.025. Epub 2021 Jun 5. J Pharm Sci. 2021. PMID: 34097976

8

Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.

Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, Taylor LS, Kumar S, Tony Zhou Q. Bhujbal SV, et al. Among authors: karki s. Acta Pharm Sin B. 2021 Aug;11(8):2505-2536. doi: 10.1016/j.apsb.2021.05.014. Epub 2021 Jun 5. Acta Pharm Sin B. 2021. PMID: 34522596 Free PMC article. Review.

9

Engineered particles demonstrate improved flow properties at elevated drug loadings for direct compression manufacturing.

Trementozzi AN, Leung CY, Osei-Yeboah F, Irdam E, Lin Y, MacPhee JM, Boulas P, Karki SB, Zawaneh PN. Trementozzi AN, et al. Int J Pharm. 2017 May 15;523(1):133-141. doi: 10.1016/j.ijpharm.2017.03.011. Epub 2017 Mar 8. Int J Pharm. 2017. PMID: 28284921

10

Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.

Tomaszewska I, Karki S, Shur J, Price R, Fotaki N. Tomaszewska I, et al. Among authors: karki s. Int J Pharm. 2013 Sep 10;453(2):380-8. doi: 10.1016/j.ijpharm.2013.05.048. Epub 2013 May 29. Int J Pharm. 2013. PMID: 23727143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

727 results

Search Page

Filters